# Correction: METTL3 enhances pancreatic ductal adenocarcinoma progression and gemcitabine resistance through modifying DDX23 mRNA N6 adenosine methylation

**Authors:** Chengjie Lin, Ting Li, Yan Wang, Shihui Lai, Yue Huang, Zhenyun Guo, Xiang Zhang, Shangeng Weng

PMC · DOI: 10.1038/s41419-025-08135-5 · Cell Death & Disease · 2026-02-25

## Full-text entities

- **Genes:** DDX23 (DEAD-box helicase 23) [NCBI Gene 9416] {aka PRPF28, SNRNP100, U5-100K, U5-100KD, prp28}, METTL3 (methyltransferase 3, N6-adenosine-methyltransferase complex catalytic subunit) [NCBI Gene 56339] {aka IME4, M6A, MT-A70, Spo8, hMETTL3}
- **Diseases:** Cell Death (MESH:D003643), pancreatic ductal adenocarcinoma (MESH:D021441)
- **Chemicals:** gemcitabine (MESH:D000093542), N6 adenosine (MESH:C054123)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12936198/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12936198/full.md

---
Source: https://tomesphere.com/paper/PMC12936198